Avicenna.AI’s CINA Head earns 510(k) clearance for emergency room triage of intracranial hemorrhages and large vessel occlusions.
Medical solutions artificial intelligence (AI) company Avicenna.AI secured 510(k) clearance from the U.S. Food & Drug Administration (FDA) this week for its CINA Head neurovascular emergency triage tool.
With a combination of deep learning and machine learning technologies, company officials said, CINA Head can automatically detect and prioritize both intracranial hemorrhage (ICH) and large vessel occlusion (LVO) from CT scans within 20 seconds, alerting the radiologist within their existing system and workflow. It is intended to help triage multiple pathologies.
More than 795,000 strokes occur annually in the United States, leading to more than 100,000 deaths. According to company data, LVO causes up to one-third of stroke-related deaths, and ICH is thought to prompt 10 percent of cases.
Related Content: FDA Approves First AI-Powered Stroke Imaging Solution
“When dealing with a stroke, time is of the essence, and being able to prioritize effectively is critical to saving lives and improving outcomes,” said Peter Chang, M.D., neuroradiologist and Avicenna.AI co-founder. “Not only does CINA Head help radiologists to identify pathologies quickly, but also to highlight those that require the most urgent care.”
Courtesy: Avicenna.AI
Based on company test results from 814 cases conducted in more than 250 imaging centers nationwide, CINA’s ICH detection capability was validated with 96-percent accuracy, 91.4-percent sensitivity, and 97.5-percent specificity. The LVO detection capability was validated with 476 cases, leading to 97.7-percent accuracy, 97.9-percent sensitivity, and 97.6-percent specificity.
The company has additional plans for AI tools that can be used in trauma and vascular fields within the next 12 months.
What a New Meta-Analysis Reveals About Fractional Flow Reserve Assessment with Computed Tomography
May 13th 2024While acknowledging variable accuracy overall with CT-derived fractional flow reserve (FFR-CT) values, researchers found that the accuracy rate increased to 90 percent for FFR-CT values greater > 0.90 and < 0.49.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
Study Finds High Concordance Between AI and Radiologists for Cervical Spine Fractures on CT
May 6th 2024Researchers found a 98.3 percent concordance between attending radiology reports and AI assessments for possible cervical spine fractures on CT, according to new research presented at the 2024 ARRS Annual Meeting.
FDA Clears AI-Powered Qualitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.